These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27699905)

  • 21. Crystallographic studies of shikimate binding and induced conformational changes in Mycobacterium tuberculosis shikimate kinase.
    Dhaliwal B; Nichols CE; Ren J; Lockyer M; Charles I; Hawkins AR; Stammers DK
    FEBS Lett; 2004 Sep; 574(1-3):49-54. PubMed ID: 15358538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and structural analysis of aromatic inhibitors of type II dehydroquinase from Mycobacterium tuberculosis.
    Howard NI; Dias MV; Peyrot F; Chen L; Schmidt MF; Blundell TL; Abell C
    ChemMedChem; 2015 Jan; 10(1):116-33. PubMed ID: 25234229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of Shikimate Kinase from Methicillin-Resistant
    Rios-Soto L; Hernández-Campos A; Tovar-Escobar D; Castillo R; Sierra-Campos E; Valdez-Solana M; Téllez-Valencia A; Avitia-Domínguez C
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An overview of mechanism and chemical inhibitors of shikimate kinase.
    Chagaleti BK; Reddy MBR; Saravanan V; B S; D P; Senthil Kumar P; Kathiravan MK
    J Biomol Struct Dyn; 2023; 41(23):14582-14598. PubMed ID: 36974959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-based in silico design of a high-affinity dipeptide inhibitor for novel protein drug target Shikimate kinase of Mycobacterium tuberculosis.
    Kumar M; Verma S; Sharma S; Srinivasan A; Singh TP; Kaur P
    Chem Biol Drug Des; 2010 Sep; 76(3):277-84. PubMed ID: 20626408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure of shikimate kinase from Mycobacterium tuberculosis reveals the dynamic role of the LID domain in catalysis.
    Gu Y; Reshetnikova L; Li Y; Wu Y; Yan H; Singh S; Ji X
    J Mol Biol; 2002 Jun; 319(3):779-89. PubMed ID: 12054870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mode of action of recombinant Mycobacterium tuberculosis shikimate kinase: kinetics and thermodynamics analyses.
    Rosado LA; Vasconcelos IB; Palma MS; Frappier V; Najmanovich RJ; Santos DS; Basso LA
    PLoS One; 2013; 8(5):e61918. PubMed ID: 23671579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cloning and overexpression in soluble form of functional shikimate kinase and 5-enolpyruvylshikimate 3-phosphate synthase enzymes from Mycobacterium tuberculosis.
    Oliveira JS; Pinto CA; Basso LA; Santos DS
    Protein Expr Purif; 2001 Aug; 22(3):430-5. PubMed ID: 11483005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of novel scaffold using ligand and structure based approach targeting shikimate kinase.
    Rahul Reddy MB; Krishnasamy SK; Kathiravan MK
    Bioorg Chem; 2020 Sep; 102():104083. PubMed ID: 32745735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
    Rajput VS; Mehra R; Kumar S; Nargotra A; Singh PP; Khan IA
    Appl Microbiol Biotechnol; 2016 Jun; 100(12):5415-26. PubMed ID: 26887318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shikimate kinase, a protein target for drug design.
    Coracini JD; de Azevedo WF
    Curr Med Chem; 2014; 21(5):592-604. PubMed ID: 24164195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural bioinformatics study of EPSP synthase from Mycobacterium tuberculosis.
    Pereira JH; Canduri F; de Oliveira JS; da Silveira NJ; Basso LA; Palma MS; de Azevedo WF; Santos DS
    Biochem Biophys Res Commun; 2003 Dec; 312(3):608-14. PubMed ID: 14680808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of an ultrafiltration-liquid chromatography/mass spectrometry (UF-LC/MS) based ligand-binding assay and an LC/MS based functional assay for Mycobacterium tuberculosis shikimate kinase.
    Mulabagal V; Calderón AI
    Anal Chem; 2010 May; 82(9):3616-21. PubMed ID: 20394394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular model of shikimate kinase from Mycobacterium tuberculosis.
    Filgueira de Azevedo W; Canduri F; Simões de Oliveira J; Basso LA; Palma MS; Pereira JH; Santos DS
    Biochem Biophys Res Commun; 2002 Jul; 295(1):142-8. PubMed ID: 12083781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanomolar competitive inhibitors of Mycobacterium tuberculosis and Streptomyces coelicolor type II dehydroquinase.
    Prazeres VF; Sánchez-Sixto C; Castedo L; Lamb H; Hawkins AR; Riboldi-Tunnicliffe A; Coggins JR; Lapthorn AJ; González-Bello C
    ChemMedChem; 2007 Feb; 2(2):194-207. PubMed ID: 17245805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the key factors that control the inhibition of type II dehydroquinase by (2R)-2-benzyl-3-dehydroquinic acids.
    Peón A; Otero JM; Tizón L; Prazeres VF; Llamas-Saiz AL; Fox GC; van Raaij MJ; Lamb H; Hawkins AR; Gago F; Castedo L; González-Bello C
    ChemMedChem; 2010 Oct; 5(10):1726-33. PubMed ID: 20815012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simulations of Shikimate Dehydrogenase from Mycobacterium tuberculosis in Complex with 3-Dehydroshikimate and NADPH Suggest Strategies for MtbSDH Inhibition.
    Punkvang A; Kamsri P; Mulholland A; Spencer J; Hannongbua S; Pungpo P
    J Chem Inf Model; 2019 Apr; 59(4):1422-1433. PubMed ID: 30840825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Finding the First Potential Inhibitors of Shikimate Kinase from Methicillin Resistant
    Rios-Soto L; Téllez-Valencia A; Sierra-Campos E; Valdez-Solana M; Cisneros-Martínez J; Gómez Palacio-Gastélum M; Castillo-Villanueva A; Avitia-Domínguez C
    Molecules; 2021 Nov; 26(21):. PubMed ID: 34771148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of new potential Mycobacterium tuberculosis shikimate kinase inhibitors through molecular docking simulations.
    Vianna CP; de Azevedo WF
    J Mol Model; 2012 Feb; 18(2):755-64. PubMed ID: 21594693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein kinase C-δ inhibitor, Rottlerin inhibits growth and survival of mycobacteria exclusively through Shikimate kinase.
    Pandey S; Chatterjee A; Jaiswal S; Kumar S; Ramachandran R; Srivastava KK
    Biochem Biophys Res Commun; 2016 Sep; 478(2):721-6. PubMed ID: 27498028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.